![Pipeline_illo_0](https://www.hivplusmag.com/media-library/pipeline-illo-0.jpg?id=32678634&width=1200&height=1572)
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2024 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
For HIV-positive people who have developed resistance to available antiretroviral medications, the pipeline of new anti-HIV drugs is something of a mixed blessing. Although there are more than two dozen new drugs in clinical trials and scores of others in preclinical development, few are expected to hit the market within the next year. 'The most promising new drugs are taking quite a while to go through development,' Lei Chou, director of the Access Project at the AIDS Treatment Data Network, says. Only two new anti-HIV drugs are in final Phase III human trials'the nonnucleoside analog capravirine and the protease inhibitor tipranavir, which is a nonpeptidic drug that has a different chemical structure and resistance profile from existing protease drugs. Other candidates are at least two years away from Food and Drug Administration approval. Among the drugs in Phase II human studies that show significant activity against drug-resistant virus are two new nucleoside reverse transcriptase inhibitors'alovudine and elvucitabine'and two nonnucleoside drugs'calanolide A and TMC-125. Another protease inhibitor effective against drug-resistant virus'TMC-114'has progressed beyond initial safety trials. But among the most exciting medications in development that appear to be active against drug-resistant HIV are fusion inhibitors, which include drugs to prevent HIV's attachment, fusion, and entry into immune system cells, according to Warner Greene, MD, Ph.D., director of the Gladstone Institute for Virology and Immunology. Among the most advanced candidates in development is the attachment inhibitor PRO-542, currently in Phase II studies; at least a dozen more are in preclinical or early human tests. Some antibody-based entry inhibitors could be so powerful that they would need to be dosed only once a week'or even less often, researchers say. 'I'm basically optimistic that we'll continue to move in a direction where there are more and more choices and providers will really be able to tailor a drug combination to meet the needs of individual patients,' says Judith Feinberg, MD, an HIV specialist and the president of the Great Lakes chapter of the American Academy of HIV Medicine, 'because there's never a one-size-fits-all approach to this disease.'
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Before AIDS, gay artist Rex drew hot men on the prowl — then he disappeared
April 11 2024 3:15 PM
Diets that mimic fasting reverse aging: study
March 07 2024 5:28 PM
PrEP without a prescription now a reality in California
February 06 2024 8:37 PM
Injectable HIV treatment, prevention: Everything you need to know
March 26 2024 3:28 PM
8 dating tips for gay men from a gay therapist
March 21 2024 2:50 PM
Happy national foreskin day!
April 04 2024 1:45 PM
The science behind U=U has been liberating people with HIV for years
June 04 2024 3:31 PM
Scarlet fever: exploring our fascination with blood
March 13 2024 1:47 PM
On Anal Sex Day, crack up with The Bottom's Digest
April 18 2024 10:22 AM
Plus: Featured Video
Latest Stories
Activist and philanthropist Bruce Bastian dies at 76
June 26 2024 1:28 PM
Yes, HIV-positive people can safely breastfeed
June 26 2024 12:59 PM
Exclusive: We kiki with Q from 'RuPaul's Drag Race'
June 24 2024 11:37 AM
Court rules to keep PrEP coverage under Obamacare
June 21 2024 5:42 PM
In honor of Juneteenth 2024, meet The Normal Anomaly
June 19 2024 1:39 PM
What is Juneteenth?
June 19 2024 11:30 AM
As Pride party season begins, the CDC urges mpox vaccinations
May 16 2024 6:52 PM
Advocacy in action with AIDSWatch
May 09 2024 12:30 PM
The Talk: Thriving with HIV
May 08 2024 10:45 AM
The Talk: What HIV isn’t
May 07 2024 10:48 AM
The Talk: Finding balance with HIV
May 06 2024 10:51 AM
Justice Dept plans to reschedule marijuana as a lower-risk drug
May 03 2024 2:40 PM
The Talk: Starting your journey with HIV
May 03 2024 2:00 PM
Why is a mother’s mental health so important? A doctor explains
May 01 2024 1:38 PM
Walmart to close all of its health care clinics
April 30 2024 12:30 PM
Vampire facial spa infected several women with HIV
April 29 2024 7:26 PM